Randomized, Double‐Blind, Placebo‐Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis

Abstract

Rilonacept was generally well tolerated and demonstrated efficacy in active systemic JIA.